Complications associated with obesity;Complicaciones asociadas a la obesidad

Revista Espanola de Nutricion Comunitaria

Volumn 14, Issue 3, 2008, Pages 156-162

  Cabrerizo, Lucio Garcia ^a   Rubio, Miguel Ángel ^a   Ballesteros, Ma Dolores ^a   Moreno Lopera, Carmen ^a  

^a Sociedad Española de Endocrinología y Nutrición ^*  (Spain)

Author keywords

Cardiovascular risk; Comorbidty; Hypertension; Metabolic s ndrome; Obesity; Type 2 diabetes

Indexed keywords

EID: 61449086463     PISSN: 11353074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Kuczmarski RJ, Flegal KM, Campbel SM, Johson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960-1991. J Am Assoc 1994;272:205-11.
2. Monereo S, Pavón I, Vega B, Alameda C, Lopez de la Torre M. Calidad de vida relacionada con la salud y obesidad. Endocrinología 2000;47:81-8.
3. Colditz G, Walter C, Willet W, Rotnitzky A, Manson J. Weightgain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-6.
4. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-9.
5. Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and risk of type 2 diabetes. Diabetes Care 2000;23:465-71.
6. Weiss R, Dziura J, Burgert T, Tamborlane W, Taksali S, Yeckel C, Allen K, Lopes M, Savoye M, Morrison J, Sherwin R, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74.
7. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995;95:2409-15.
8. McTernan CL, McTernan PG, Harte AL, Barnett AH, Kumar S. Resistin central obesity and type 2 diabetes. Lancet 2002;35:46-7.
9. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001;7:941-6.
10. Large V, Amer P. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipemia. Diabetes Metab 1998;24:409-18.
11. Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH. Splanchnic insulin metabolism in obesity: Influence of body fat distribution. J Clin Invest 1986;78:1648-57.
12. Shimura R, Tatsumi K, Nakamura A, et al. Fat Accumulation, Leptin, and Hypercapnia in Obstructive Sleep Apnea-Hypopnea Syndrome. Chest 2005;127:543-9.
13. Phipps PR, Starritt E, Caterson I, et al. Association of serum leptin with hypoventilation in human obesity. Thorax 2002;57:75-6.
14. Yee BJ, Cheung J, Phipps P, et al. Treatment of Obesity Hypoventilation Syndrome and Serum Leptin. Respiration 2005.
15. Reaven GM, Chen YDI. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diab Metab Rev 1988;4:639-52.
16. Toumiletho J, Zimmet P, Wolf E, Taylor R, Ram P, King H. Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of fiji. Am J Epidemiol 1988;127:321-36.
17. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. Uric acid and coronary heart disease risk: evidence for a role of acid uric in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol 1995;142:288-94.
18. Rocchini AP. Insulin and renal sodium retention in obese adolescent. Hypertension 1989;14:367-74.
19. Landsberg L, Krieger DR. Obesity, metabolism, and sympathetic nervous system. Am J Hypertension 1989;2:1255-325.
20. Staessen J, Fagard R, Amery A. The relationship between body weight and blood pressure. J Human Hypertension 1988;2:207-17.
21. Huang, Z,Willett, WC, Manson, JE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med 1998;128:81.
22. Neter JE, Stam BE, Kok FJ, Grobbee DE. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003;42:878.
23. Modan, M, Almog, S, Fuchs, Z, et al. Obesity, glucose intolerance, hyperinsulinemia, and response to antihypertensive drugs. Hypertension 1991;17:565.
24. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55:652-8.
25. Willett WC, Browne ML, Bain C, et al. Relative weight and risk of breast cancer among premenopausal women. Am J Epidemiol. 1985;122:731-40.
26. Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med 1992;116:535-9.
27. Liel Y, Edwards J, Spiecer K. Effects of race and body habitus on bone mineral density (BMD) of the radius, hip, and spine in premenopausal women. J Clin Endocrinol Metab 1988;66:1247-50.
28. Grodstein F, Goldman MB, Cramer DW. Body mass index and ovulatory infertility. Epidemiology 1994;5:247-50.
29. Rich-Edwards JW, Goldman MB, Willett WC, Hunter DJ, Stampfer, Colditz GA, Manson JE. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol 1994;171:171-7.
30. Diamanti-Kandarakis E, Bergiele A. The influence of obesity on hyperandrogenism and infertility in the female. Obes Rev 2001;2(4):231-8.